{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T21:47:44Z","timestamp":1788731264755,"version":"build-2803163510"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple evidence suggests that thyroid function is associated with polycystic ovary syndrome (PCOS), but whether thyroid function is causally related to PCOS is unclear. To investigate whether the association reflect causality, a Mendelian randomization (MR) analysis was conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single nucleotide polymorphisms (SNPs) involved in this study were acquired from The ThyroidOmics Consortium and the IEU Open Genome-wide association study (GWAS) database, respectively. In forward MR analysis, we included normal free thyroxine (FT4, n=49,269), normal thyroid-stimulating hormone (TSH, n=54,288), hypothyroidism (n=53,423) and hyperthyroidism (n=51,823) as exposure. The outcome was defined as PCOS in a sample size of 16,380,318 individuals. The exposure in the reverse MR analyses was chosen as PCOS, while the outcome consisted of the four phenotypes of thyroid function. The inverse-variance weighted (IVW) method was performed as the major analysis, supplemented by sensitivity analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The occurrence of PCOS was associated with increased risk of hyperthyroidism (IVW, OR=1.08, 95%CI=1.02-1.13, P=0.004). No evidence suggested that other phenotypes of thyroid function were related to PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings demonstrate a cause-and-effect connection between PCOS and hyperthyroidism. The study established foundation for further investigation for interaction between thyroid function and PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2024.1364157","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:32:06Z","timestamp":1711067526000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Thyroid function and polycystic ovary syndrome: a Mendelian randomization study"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhendan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac001","article-title":"Deconstructing a syndrome: genomic insights into Pcos causal mechanisms and classification","volume":"43","author":"Dapas","year":"2022","journal-title":"Endocr Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013505","article-title":"Metformin for ovulation induction (Excluding gonadotrophins) in women with polycystic ovary syndrome","volume":"12","author":"Sharpe","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (Pcos): current perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl Clin Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3390\/biomedicines10040750","article-title":"Impact of thyroid function on pregnancy and neonatal outcome in women with and without Pcos","volume":"10","author":"Obermayer-Pietsch","year":"2022","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3390\/antiox12111983","article-title":"Association of mitochondrial variants with the joint occurrence of polycystic ovary syndrome and Hashimoto's thyroiditis","volume":"12","author":"Zeber-Lubecka","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1095\/biolreprod.115.136515","article-title":"Dietary-induced chronic hypothyroidism negatively affects rat follicular development and ovulation rate and is associated with oxidative stress","volume":"94","author":"Meng","year":"2016","journal-title":"Biol Reprod"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0377","article-title":"Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: A cohort study","volume":"8","author":"Glintborg","year":"2019","journal-title":"Endocr Connect"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17722","article-title":"Frequency of subclinical hypothyroidism in women with polycystic ovary syndrome","volume":"13","author":"Raj","year":"2021","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2174\/1573399818666220426090324","article-title":"Is there a relation between hypothyroidism and polycystic ovary syndrome and its metabolic components","volume":"19","author":"Bonakdaran","year":"2023","journal-title":"Curr Diabetes Rev"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S405942","article-title":"Thyroid hormones and cardiometabolic risk factors in Saudi women with polycystic ovary syndrome: A cross-sectional study","volume":"15","author":"Saeed","year":"2023","journal-title":"Int J Womens Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1245106","article-title":"The prevalence of thyroid dysfunction and hyperprolactinemia in women with Pcos","volume":"14","author":"van der Ham","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1038\/s41467-018-06356-1","article-title":"Genome-wide analyses identify a role for Slc17a4 and Aadat in thyroid hormone regulation","volume":"9","author":"Teumer","year":"2018","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00721-z","article-title":"Thyroid function, sex hormones and sexual function: A Mendelian randomization study","volume":"36","author":"Kjaergaard","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.3390\/ijerph17072422","article-title":"Increased risk of polycystic ovary syndrome and it's comorbidities in women with autoimmune thyroid disease","volume":"17","author":"Ho","year":"2020","journal-title":"Int J Env Res Public Health"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.109714","article-title":"Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from eastern India","volume":"17","author":"Sinha","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000135626","article-title":"Immune-endocrine interactions in autoimmune thyroid diseases","volume":"15","author":"Klecha","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000078438","article-title":"Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' Disease (Th2)","volume":"11","author":"Phenekos","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1225629","article-title":"Effect of testosterone on thyroid weight and function in iodine deficient castrated rats","volume":"41","author":"Bahrami","year":"2009","journal-title":"Horm Metab Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00794","article-title":"Androgen-induced immunosuppression","volume":"9","author":"Gubbels Bupp","year":"2018","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00737-021-01158-9","article-title":"Free testosterone is related to aspects of cognitive function in women with and without polycystic ovary syndrome","volume":"25","author":"Sukhapure","year":"2022","journal-title":"Arch Womens Ment Health"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14219","article-title":"Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury","volume":"7","author":"Song","year":"2019","journal-title":"Physiol Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3390\/nu13061848","article-title":"Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility","volume":"13","author":"Calcaterra","year":"2021","journal-title":"Nutrients"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00464.2016","article-title":"Insulin resistance and normal thyroid hormone levels: prospective study and metabolomic analysis","volume":"312","author":"Ferrannini","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B26","article-title":"Metformin ameliorates insulin resistance, thyroid nodules and thyroid function","volume":"15","author":"Ji","year":"2023","journal-title":"Am J Transl Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102791","article-title":"Inflammatory and anti-inflammatory parameters in Pcos patients depending on body mass index: A case-control study","volume":"11","author":"Vasyukova","year":"2023","journal-title":"Biomedicines"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.749","article-title":"Cd40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases","volume":"9","author":"Smith","year":"1999","journal-title":"Thyroid"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4391","article-title":"Coexpression of Cd40 and class ii antigen Hla-Dr in Graves' Disease thyroid epithelial cells","volume":"84","author":"Faure","year":"1997","journal-title":"Clin Immunol Immnopathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364375","article-title":"A Cd40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of Cd40 tissue-specific expression","volume":"8","author":"Jacobson","year":"2007","journal-title":"Genes Immun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200311","article-title":"Genetically driven target tissue overexpression of Cd40: A novel mechanism in autoimmune disease","volume":"189","author":"Huber","year":"2012","journal-title":"J Immunol (Baltimore Md 1950)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1364157\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:32:12Z","timestamp":1711067532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1364157\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":31,"alternative-id":["10.3389\/fendo.2024.1364157"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1364157","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"article-number":"1364157"}}